{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T15:22:46Z","timestamp":1743088966135,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":15,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071607947"},{"type":"electronic","value":"9781071607954"}],"license":[{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-1-0716-0795-4_21","type":"book-chapter","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T16:11:58Z","timestamp":1600704718000},"page":"405-422","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Flavivirus DNA Vaccine Design and Adjuvant Selection"],"prefix":"10.1007","author":[{"given":"Lei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Honda-Okubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolai","family":"Petrovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,22]]},"reference":[{"key":"21_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.21775\/cimb.022.017","volume":"22","author":"L Li","year":"2017","unstructured":"Li L, Petrovsky N (2017) Molecular adjuvants for DNA vaccines. Curr Issues Mol Biol 22:17\u201340","journal-title":"Curr Issues Mol Biol"},{"issue":"2\u20133","key":"21_CR2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jbiotec.2012.08.012","volume":"162","author":"L Li","year":"2012","unstructured":"Li L, Saade F, Petrovsky N (2012) The future of human DNA vaccines. J Biotechnol 162(2\u20133):171\u2013182","journal-title":"J Biotechnol"},{"issue":"2","key":"21_CR3","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.vaccine.2011.10.085","volume":"30","author":"KR Porter","year":"2011","unstructured":"Porter KR et al (2011) Immunogenicity and protective efficacy of a vaxfectin-adjuvanted tetravalent dengue DNA vaccine. Vaccine 30(2):336\u2013341","journal-title":"Vaccine"},{"issue":"2","key":"21_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1089\/088282403322017910","volume":"16","author":"C Nukuzuma","year":"2003","unstructured":"Nukuzuma C et al (2003) Enhancing effect of vaxfectin on the ability of a Japanese encephalitis DNA vaccine to induce neutralizing antibody in mice. Viral Immunol 16(2):183\u2013189","journal-title":"Viral Immunol"},{"issue":"1","key":"21_CR5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1046\/j.1365-2567.2001.01201.x","volume":"103","author":"Y Ara","year":"2001","unstructured":"Ara Y et al (2001) Zymosan enhances the immune response to DNA vaccine for human immunodeficiency virus type-1 through the activation of complement system. Immunology 103(1):98\u2013105","journal-title":"Immunology"},{"issue":"36","key":"21_CR6","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.1016\/j.vaccine.2012.06.021","volume":"30","author":"Y Honda-Okubo","year":"2012","unstructured":"Honda-Okubo Y, Saade F, Petrovsky N (2012) Advax, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses. Vaccine 30(36):5373\u20135381","journal-title":"Vaccine"},{"issue":"Pt 6","key":"21_CR7","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1099\/vir.0.019190-0","volume":"91","author":"M Lobigs","year":"2010","unstructured":"Lobigs M et al (2010) An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses. J Gen Virol 91(Pt 6):1407\u20131417","journal-title":"J Gen Virol"},{"issue":"2","key":"21_CR8","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.bioelechem.2006.11.001","volume":"70","author":"D Cukjati","year":"2007","unstructured":"Cukjati D et al (2007) Real time electroporation control for accurate and safe in vivo non-viral gene therapy. Bioelectrochemistry 70(2):501\u2013507","journal-title":"Bioelectrochemistry"},{"issue":"5","key":"21_CR9","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1115\/1.2768380","volume":"129","author":"SM Becker","year":"2007","unstructured":"Becker SM, Kuznetsov AV (2007) Local temperature rises influence in vivo electroporation pore development: a numerical stratum corneum lipid phase transition model. J Biomech Eng 129(5):712\u2013721","journal-title":"J Biomech Eng"},{"issue":"11\u201312","key":"21_CR10","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.vaccine.2003.10.011","volume":"22","author":"CJ Wu","year":"2004","unstructured":"Wu CJ et al (2004) In vivo electroporation of skeletal muscles increases the efficacy of Japanese encephalitis virus DNA vaccine. Vaccine 22(11\u201312):1457\u20131464","journal-title":"Vaccine"},{"issue":"4","key":"21_CR11","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.vaccine.2009.10.111","volume":"28","author":"BD Livingston","year":"2009","unstructured":"Livingston BD et al (2009) Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques. Vaccine 28(4):1056\u20131061","journal-title":"Vaccine"},{"issue":"10","key":"21_CR12","doi-asserted-by":"publisher","first-page":"5257","DOI":"10.1128\/JVI.00055-07","volume":"81","author":"A Luckay","year":"2007","unstructured":"Luckay A et al (2007) Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques. J Virol 81(10):5257\u20135269","journal-title":"J Virol"},{"issue":"40","key":"21_CR13","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.1016\/j.vaccine.2008.03.058","volume":"26","author":"AJ Simon","year":"2008","unstructured":"Simon AJ et al (2008) Enhanced in vivo transgene expression and immunogenicity from plasmid vectors following electrostimulation in rodents and primates. Vaccine 26(40):5202\u20135209","journal-title":"Vaccine"},{"issue":"37","key":"21_CR14","doi-asserted-by":"publisher","first-page":"6352","DOI":"10.1016\/j.vaccine.2011.04.116","volume":"29","author":"A Schneeweiss","year":"2011","unstructured":"Schneeweiss A et al (2011) A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII. Vaccine 29(37):6352\u20136357","journal-title":"Vaccine"},{"issue":"2","key":"21_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.tvjl.2008.09.019","volume":"183","author":"P Li","year":"2008","unstructured":"Li P et al (2008) Enhancement of humoral and cellular immunity in mice against Japanese encephalitis virus using a DNA prime - protein boost vaccine strategy. Vet J 183(2):210\u2013216","journal-title":"Vet J"}],"container-title":["Methods in Molecular Biology","Vaccine Delivery Technology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-0795-4_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T16:17:26Z","timestamp":1600705046000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-0716-0795-4_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,22]]},"ISBN":["9781071607947","9781071607954"],"references-count":15,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-0795-4_21","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2020,9,22]]},"assertion":[{"value":"22 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}